Rituximab in primary Sjögren's syndrome: a ten-year journey. - Wikidata - awgldk - TriplyDB

Rituximab in primary Sjögren's syndrome: a ten-year journey.

Rituximab in primary Sjögren's syndrome: a ten-year journey.

http://www.wikidata.org/entity/Q34432465

about

T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.Monoclonal antibody therapy for neuromyelitis optica spectrum disorder: current and future.Enhanced Bruton's Tyrosine Kinase Activity in Peripheral Blood B Lymphocytes From Patients With Autoimmune Disease.The significance and predictive value of free light chains in the urine of patients with chronic inflammatory rheumatic disease.Cutaneous and Mucosal Manifestations of Sjögren's Syndrome.Chronic Autoimmune Epithelitis in Sjögren's Syndrome and Primary Biliary Cholangitis: A Comprehensive Review.Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: a pilot study.

P2860

Q26859226-C673294A-ED63-42AA-B231-9CB399547EB7 Q38355697-14C646D2-87F5-47C8-9967-FC2385CD3978 Q38816869-BD0ABD8B-1EDB-4DED-989F-687873529D12 Q38988830-E820CD9C-50FF-48FB-A40D-212E28125F2E Q39297229-692EBCBD-CC23-4049-8DCD-DF1AAC8FFAFE Q40067064-03006E8D-F2AD-4668-90E8-9021706ED774 Q47146987-7BD494D6-B015-4F70-8D92-A5CC83248FC5 Q53194059-54951906-AD3C-4A8E-ADCC-383EC20137F9

P2860

Rituximab in primary Sjögren's syndrome: a ten-year journey.

http://www.wikidata.org/entity/Q34432465

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Rituximab in primary Sjögren's syndrome: a ten-year journey.

@ast

Rituximab in primary Sjögren's syndrome: a ten-year journey.

@en

Rituximab in primary Sjögren's syndrome: a ten-year journey.

@nl

type

label

Rituximab in primary Sjögren's syndrome: a ten-year journey.

@ast

Rituximab in primary Sjögren's syndrome: a ten-year journey.

@en

Rituximab in primary Sjögren's syndrome: a ten-year journey.

@nl

prefLabel

Rituximab in primary Sjögren's syndrome: a ten-year journey.

@ast

Rituximab in primary Sjögren's syndrome: a ten-year journey.

@en

Rituximab in primary Sjögren's syndrome: a ten-year journey.

@nl

P1433

Q34432465-62EF2407-E280-4177-9A79-6E9CD4C2C571

P1476

Q34432465-4E8EF64E-C1E3-44A0-A8BE-991BBDE2E44F

P2093

Q34432465-08E6FFFA-1BF7-4338-B615-C2F6981B5F89

Q34432465-9C59969A-3767-4535-9F9A-598EEA9BA0DB

Q34432465-FCD30E2F-EBE4-4901-A5A1-55B36E54B161

P2860

Q34432465-06F5FF91-41FB-4044-8EB9-E12721E3D187

Q34432465-098D6AB2-8AA6-4BB4-8D94-FB1900759AAB

Q34432465-0F725ED8-CA71-409A-9DFC-5F7DABB26ED8

Q34432465-1CF14158-6E59-4801-9109-36126F85CCCE

Q34432465-1DBC05CB-FD84-4AC1-A8DB-B6AAA24F4ABA

Q34432465-1E13BF65-2721-4E5D-A072-3B44E435F2CC

Q34432465-227D5651-EC4C-4131-9FC8-C7D71FB6A4E4

Q34432465-22DBA2B4-7C4D-4DBD-BD94-AA7705949D27

Q34432465-24824986-7F62-43F5-BD77-4142F12D58DA

Q34432465-26AC7CBE-3BF1-4F53-9070-E75C7D465FEB

P304

Q34432465-3023A83F-E752-496A-AB76-8EBFA3890A43

P31

Q34432465-DF41BAB4-D036-4419-B6A4-0D87C879435D

P356

Q34432465-10E1D963-C1E2-48E8-9A56-4407DBA16AA8

P433

Q34432465-0EAE5BF9-BD0F-419A-8DA2-EBA2D60C741D

P478

Q34432465-62F9B0B0-107A-49D8-83FA-2B496614AEB3

P50

Q34432465-0273EEDE-EFC2-4AC0-BBED-05D17A59ED2A

Q34432465-A719D5A2-7E81-4A7D-B5F5-16B32A514B8E

Q34432465-BEE4E09E-4400-4315-9DB8-BB29FB3E4297

Q34432465-CAE18A1A-B624-433D-B904-53B91D6589C5

Q34432465-D6B5D440-CD3C-44B0-ACCD-62206B8E30BE

P577

Q34432465-D660EA37-1306-407A-B011-D88ABD920CB5

P698

Q34432465-1CB3590E-F013-44D6-8CF9-C046F24DAD7B

P356

0961203314546023

P1433

P1476

Rituximab in primary Sjögren's syndrome: a ten-year journey

@en

P2093

A Alunno

http://www.w3.org/2001/XMLSchema#string

F Carubbi

http://www.w3.org/2001/XMLSchema#string

R Gerli

http://www.w3.org/2001/XMLSchema#string

P2860

Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.

Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome.

Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.

CD4(-)CD8(-) T-cells in primary Sjögren's syndrome: association with the extent of glandular involvement.

Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).

B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue.

Lymphoid neogenesis in chronic inflammatory diseases.

Rituximab therapy for primary Sjögren's syndrome: an open-label clinical trial and mechanistic analysis.

Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets.

P304

1337-1349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0961203314546023

http://www.w3.org/2001/XMLSchema#string

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Roberto Giacomelli

Elena Bartoloni

P577

2014-08-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25096066

http://www.w3.org/2001/XMLSchema#string